Poster Presentation News
- Rheonix CARD™ Technology Demonstrates Utility in Multiple Molecular ... - Business Wire (press release) Thursday, 29 July 2010, 4:01 pm
Rheonix CARD™ Technology Demonstrates Utility in Multiple Molecular ...Business Wire (press release)In the poster presentation entitled “Fully Integrated, Automatic, and Rapid Molecular Detection. […] - Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results - PR Newswire (press release) Thursday, 29 July 2010, 11:32 am
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 ResultsPR Newswire (press release)... London, UK, was published in the online version of the Journal of Clinical Investigation; - A poster pres. […] - Data on VIVUS' Qnexa® To Be Presented at the National Medical Association ... - PR Newswire (press release) Thursday, 29 July 2010, 11:16 am
Data on VIVUS' Qnexa® To Be Presented at the National Medical Association ...PR Newswire (press release)The data will also be presented in a poster presentation session on Tuesday, August 3rd. Presen. […] - Double-Boosted Protease-Inhibitor Therapy May Change Lipid Profiles for ... - DG News Wednesday, 28 July 2010, 2:32 pm
Double-Boosted Protease-Inhibitor Therapy May Change Lipid Profiles for ...DG News... dose and lopinavir," said Humberto Jimenez, PharmD, Rutgers University, Piscataway, New Jersey, speaking here at h. […] - Factors Identified to Help At-Risk HIV Patients With Low CD4 Counts to Gain ... - DG News Tuesday, 27 July 2010, 4:41 pm
Factors Identified to Help At-Risk HIV Patients With Low CD4 Counts to Gain ...DG News... during the first 6 months after initiating highly active antiretroviral therapy (P < .001), Dr. Tang said at h. […] - Students improve aerial vehicles - Texas A&M The Battalion Tuesday, 27 July 2010, 12:16 am
Students improve aerial vehiclesTexas A&M The BattalionIn addition to lab work, participating students attend workshops that teach presentation skills, and work on a formal poster presentation of rese. […] - FDA approves another triple-drug combination for resistant hypertension: Tribenzor - TheHeart.Org Monday, 26 July 2010, 8:13 pm
FDA approves another triple-drug combination for resistant hypertension: TribenzorTheHeart.Org... in the phase 3 TRINITY trial, and the results were reported in a poster presentation at the American S. […] - Now More Than Ever, AIDS 2010 - Colorful Times Monday, 26 July 2010, 6:44 pm
Now More Than Ever, AIDS 2010Colorful TimesHaving attended my first AIDS conference in Mexico City in 2008, and now due to give a poster presentation at AIDS 2010, I initially took a sophomoric 'been. […] - Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data From Phase ... - PR Newswire (press release) Monday, 26 July 2010, 11:01 am
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data From Phase ...PR Newswire (press release)Poster presentation: 15th Congress of the European Hematology Association, June 10-13, 2010,. […] - Cytokinetics Announces Presentation of Phase I Data Relating to CK-2017357 at ... - MarketWatch (press release) Thursday, 22 July 2010, 11:36 am
Cytokinetics Announces Presentation of Phase I Data Relating to CK-2017357 at ...MarketWatch (press release)... a novel fast skeletal muscle troponin activator, was presented in the Late Breaking News. […] - Cytokinetics Announces Presentation of Phase I Data Relating to CK-2017357 at the XII International Congress on ... Thursday, 22 July 2010, 11:30 am
SOUTH SAN FRANCISCO, CA--(Marketwire - 07/22/10) - Cytokinetics, Incorporated (NASDAQ: CYTK - News ) announced today that a poster summarizing data from a Phase I clinical trial of CK-2017357, a novel. […]
